Stamos Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Stamos Capital Partners's LLY Position: Q1 2026 in Review
Stamos Capital Partners increased its Eli Lilly (LLY) stake by 28% in Q1 2026, buying an estimated $1.37M and bringing the position to 6,129 shares worth $5.64M. The position accounts for 0.88% of the portfolio, ranked #32.
Stamos Capital Partners first reported a position in LLY in Q4 2018 and has held it in 15 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Stamos Capital Partners held 6,129 shares of Eli Lilly worth $5.64M as of Q1 2026.
- Stamos Capital Partners bought 1,351 Eli Lilly shares in Q1 2026, an estimated $1.37M.
- Eli Lilly made up 0.88% of Stamos Capital Partners's portfolio in Q1 2026, its #32 holding.
- Stamos Capital Partners first reported a position in Eli Lilly in Q4 2018 and has held it in 15 quarters since.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Stamos Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.